Skip to content
Latest News
Equals Group Shares Jump On Robust Revenue Growth

Equals Group (LON: EQLS) shares jumped Monday morning after the company released a trading update, telling investors that revenue growth "remains robust" despite unfavourable global macroeconomic conditions.

Sam Boughedda
Apple Speeds Up Plans to Move iPhone Production Out of China

Apple (NASDAQ: AAPL) is reportedly speeding up its plans to shift iPhone production away from China following worker protests as a result of Covid regulations at the largest iPhone factory in the world.

Sam Boughedda
Vodafone Shares Rise as CEO to Step Down

Vodafone (LON: VOD) announced early Monday that the company's Chief Executive Officer, Nick Read, has agreed to step down on December 31.

Sam Boughedda
US Dollar Index Surges on Nonfarm Payroll Data. What’s Next?

The US Dollar Index today surged 85 pips higher following the release of upbeat nonfarm payroll data, which showed that the country created 263,000 new jobs, beating analysts' estimates of 200,000 new jobs.

Simon Mugo
Anavex Life (AVXL) Stock Rallied 67.3% After Trial Met Endpoints

The Anavex Life Sciences Corp (NASDAQ: AVXL) stock price rallied 67.3% after releasing the phase 2b/3 clinical trial of its oral ANAVEX®2-73 (blarcamesine) for the treatment of mild cognitive impairment (MCI) due to

Simon Mugo
Polkadot Price Trying to Base, Upside Risks and Prediction

A push higher for Polkadot this week has sent a bullish, short-term, technical analysis signal on the chart. This price action sets the risk for a higher price forecast into December and maybe on into early 2023.

Steve Miley
Beam Therapeutics Shares Jump After FDA Lifts BEAM-201 Clinical Hold

Beam Therapeutics (NASDAQ: BEAM) shares have rallied premarket after the company revealed that the US Food and Drug Administration (FDA) has lifted the clinical hold for BEAM-201.

Sam Boughedda
Rigel Pharma (RIGL) Stock Soared 40% as FDA Approves New Drug

The Rigel Pharmaceuticals Inc (NASDAQ: RIGL) stock price soared 40.5% after the US Food and Drug Administration (FDA) approved its leukemia drug known as REZLIDHIAâ„¢ (olutasidenib).

Simon Mugo
Rio Tinto Downgraded to Neutral at Citi

Rio Tinto (LON: RIO) (NYSE: RIO) was downgraded to Neutral from Buy at Citi on Thursday following its Capital Markets Day event. Analyst

Sam Boughedda
Avacta Shares Have Fallen 14.9% in One Month. Are They a Buy?

The Avacta Group Plc (LON: AVCT) share price fell 14.9% in one month after hitting the 140p resistance zone and bouncing off it in late October and early November. For those interested in the stock, let’s dive into its fundam

Simon Mugo
Royal Caribbean Shares Gain On Record Black Friday

Royal Caribbean (NYSE: RCL) shares gained Thursday after the company said Black Friday was the cruise line’s single largest booking day in its 53-year history.

Sam Boughedda
Next Shares Mostly Flat Following Joules Rescue Deal

Fashion retailer Next plc (LON: NXT) announced Thursday that it has bought Joules Group (LON: JOUL) with founder Tom Joule in a £34 million rescue deal.

Sam Boughedda
Why Tern Shares Surged 9.81% on Device Authority Contract Wins

The Tern PLC (LON: TERN) share price surged by 9.81% after revealing that its portfolio company, Device Authority Limited, had won a contract worth $1.2 million over five years from an existing client.

Simon Mugo
Wizz Air Shares Gain On Positive Demand Trends

Wizz Air (LON: WIZZ) reported a 70% rise in passenger numbers year on year in November, providing further evidence that the airline's turnaround continues.

Sam Boughedda
GSTechnologies (GST) Shares Plunged 13.2% As Auditor Resigns

The GSTechnologies Ltd (LON: GST) share price plunged 13.2% after the company’s auditor Elderton Audit Pty Ltd, resigned from the role. Investors reacted negatively despite the move originating from a change in strategy by th

Simon Mugo
Asos Interim CFO to Join Softcat

Asos (LON: ASC) interim Chief Financial Officer (CFO) Katy Mecklenburgh will leave the online fashion retailer in around six months to join Softcat (LON: SCT), the company said on Friday.

Sam Boughedda
GBPUSD Price Analysis: Pound Rallies Against the Weak Dollar

The GBPUSD currency pair was trading over 239 pips at writing, starting the last month of the year on a high note despite the lack of news released from the UK docket.

Simon Mugo
Hillstream Biopharma (HILS) Stock Surged 22.4%. Here’s Why.

The Hillstream Biopharma Inc (NASDAQ: HILS) stock price surged 22.4% after revealing that it had developed proprietary targeted biologics, Knob Quatrabodiesâ„¢ (HSB-1940), against PD-1.

Simon Mugo
Mullen (MULN) Stock Rallied 17% on Closing the ELMS Acquisition

The Mullen Automotive Inc (NASDAQ: MULN) stock price rallied 17.1% after revealing that it had closed the acquisition of the Electric Last Mile Solutions' (ELMS) assets in an all-cash deal worth $105 million.

Simon Mugo
Yellen Calls For Crypto Regulation, ECB Says Bitcoin Shouldn’t Be Legitimised

US Treasury Secretary, Janet Yellen calls for crypto regulation, Fed Chair Jerome Powell lifts cryptocurrencies and riskier assets with speech, and the ECB pushes back against legitimising Bitcoin.

Steve Miley
Analysis Stocks Markets Strategies